TWO · Healthcare

UniPharma Co., Ltd. (6621)

Drug Manufacturers - Specialty & Generic

UniPharma Co., Ltd. (6621) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6621

P/E ratio

18.00

UniPharma Co., Ltd. (6621) — FAQ

What is 6621's P/E ratio?

The price-to-earnings (P/E) ratio for UniPharma Co., Ltd. (6621) is 18.00 (data as of 2026-05-23).

Does UniPharma Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for UniPharma Co., Ltd. (6621). Check the MyAverix Finance app for the latest dividend data.

What sector is UniPharma Co., Ltd. in?

UniPharma Co., Ltd. (6621) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 6621 listed on?

6621 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)